Design Characteristics, Risk of Bias, and Reporting of Randomised Controlled Trials Supporting Approvals of Cancer Drugs by European Medicines Agency, 2014-16: Cross Sectional Analysis March 15, 2026
Transformative Models to Promote Prescription Drug Innovation and Access: A Landscape Analysis March 15, 2026
Patients’ Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey March 15, 2026
Application of Orphan Drug Designation to Cancer Treatments (2008-2017): A Comprehensive and Comparative Analysis of the USA and EU March 15, 2026
Public Sector Financial Support for Late Stage Discovery of New Drugs in the United States: Cohort Study March 15, 2026
Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion March 15, 2026
Variation in Prescription Drug Prices By Retail Pharmacy Type: A National Cross-Sectional Study March 15, 2026
Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use March 15, 2026
Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications March 15, 2026